AI Summary & Key Takeaways
AI InsightThe overall survival and meanESAS score were not related (P > 0.05).CONCLUSION: ESAS contributes significantly to improve general medical condition of patients withlung cancer.
📌 3 Key Takeaways
Abstract
INTRODUCTION AND AIM: Symptom palliation is important in terms of improving quality of life andtherapy compliance in patients diagnosed with lung cancer. In this study, we intend to describe thetumor symptoms and related factors with Edmonton Symptom Assessment Scale (ESAS) in patientswho admitted to a palliative care unit.MATERIALS AND METHODS: Two hundred and ninety patients with lung cancer who admitted toour tertiary outpatient palliative clinic were retrospectively reviewed. Pathological diagnosis, stage,demographic features, comorbidities, treatment modalities, and ESAS score were recorded. Survivalwas analyzed using Kaplan–Meier analysis.RESULTS: There was no relation between stage of disease and ESAS score. The mean sleepvariance score was significantly higher in Stage IV patients compared to all other groups (P = 0.038).The scores of cough and how they felt themselves were significantly higher in patients withmetastatic lymph node (n = 30; P = 0.016 and P = 0.027, respectively). The presence of diabetesmellitus was found to be significantly related to higher sadness and anxiety score (P = 0.046 andP = 0.023, respectively). Treatment modalities (Group 1: best supportive care [n = 22] and Group 2:others [n = 268]) did not affect the mean ESAS score (P > 0.05). The overall survival and meanESAS score were not related (P > 0.05).CONCLUSION: ESAS contributes significantly to improve general medical condition of patients withlung cancer. Comorbidities should be considered along with ESAS during cancer management.Symptom score evaluation and proper palliative treatment is important in lung cancer patients.Anyway, the treatment period of lung cancer is already difficult enough, so physicians should facilitatethis process for patients.